INTRODUCTION
Endotoxin (lipopolysaccharide A) from the cell wall of Gram-negative bacteria produces symptoms of septicemia, which is increasingly regarded as a disease of the endothelium. 1 Many complications in the septic syndrome, such as multiple organ dysfunction, are attributed to activation of the inflammatory cascade and coagulation disturbances. 2 Excessive capillary leakage and subsequent local hypovolemia, particularly in the gut, are probably an important pathophysiological factor promoting the development of such organ dysfunction. 3 What molecules are responsible for the capillary leakage is not clear, but one or several substances involved in the inflammatory cascade mediate widening of the endothelial gaps. 4 A cytokine widely studied in cancer research is the vascular endothelial growth factor (VEGF), which stimulates growth of 'leaky' microvessels. 5, 6 Interestingly, VEGF rapidly increases the permeability of other blood vessels as well, and is known to be as much as 50,000 times more potent than histamine. 5 VEGF is also a vasodilator, 6 and vasodilation is a prominent feature of the septic syndrome. Hence, several clinical characteristics of the septic syndrome are mimicked by VEGF.
The present report examines whether VEGF secretion is increased in response to a bolus injection of endotoxin in rabbits. The degree of concentration change in plasma and the spatial relationship to the bolus injection were investigated. Samples were obtained in the course of a project which has demonstrated that vitamin A shortens the halflife of endotoxin, 7 thereby allowing an evaluation of the potential effect of prophylaxis and early treatment by with vitamin A on the plasma concentration of VEGF.
MATERIALS AND METHODS
After approval by the local Ethics Committee for Experimentation on Animals, 30 New Zealand white Brief report
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Vascular endothelial growth factor (VEGF) is a cytokine that greatly increases vascular permeability and thereby promotes hypovolemia. The present study examines whether the plasma VEGF concentration is increased by a bolus injection of endotoxin 20 mg/kg in 30 rabbits, and whether the response is modified by vitamin A, which doubles the endotoxin clearance. The results show that endotoxin stimulates a gradual increase in the VEGF concentration to a peak 5 h later which is approximately 100 times higher than the baseline concentration. No statistically significant difference was found between the rabbits that received no further treatment (n = 10) and the ones that were given 1000 IE/kg of vitamin A intravenously 1 h before (n = 10) or after (n = 10) the endotoxin. The rise in VEGF correlated with the development of fever, and the VEGF concentrations were higher in animals with a severely affected physical status as judged by the breathing pattern and changes in posture or reactivity. In conclusion, release of VEGF is part of the cytokine response to endotoxin with a peak occurring 5 h after a bolus injection, and the rise is pronounced also in the presence of a high endotoxin clearance.
rabbits with body weights of 2.6-3.6 kg (mean, 3.1 kg) were studied. The animals had free access to water and food (content of vitamin A, 12,000 IE/kg) but fasted overnight before the experiment started. A cannula for the injection was placed in a marginal ear vein under topical anesthesia, and another one used for blood sampling was inserted into the central ear artery. A half-isotonic 2.5% glucose-electrolyte solution was infused slowly (5 ml/h) during the first 10 h of the experiment to compensate for basal fluid losses.
All animals were given an intravenous injection of 20 mg/kg of endotoxin (Escherichia coli O111:B4; Sigma-Aldrich, St Louis, MO, USA), which results in fever but not in shock. 8 The rabbits were randomly allocated to 3 groups of 10 animals. The control group received no further treatment. The prophylaxis group was given an intravenous injection of 1000 IE/kg of retinyl palmitate (Arovite, Roche, Basel, Switzerland) 60 min before the injection of endotoxin. Animals in the treatment group were given the same amount of retinyl palmitate 60 min after the endotoxin was injected.
Arterial blood was collected in EDTA tubes at 0, 20, 50, 90, 120, 180, 240, 300, and 540 min and also 24 h and 7 days after the injection of endotoxin. The samples were immediately centrifuged at 2000 g (4°C) for 15 min and stored at -70°C until analyzed. The plasma concentration of VEGF was measured using an immunoassay kit for human specimens (Quantikine DVE00, R&D Systems, Minneapolis, MN, USA). No specific reagents for rabbit VEGF are commercially available, but the consistent pattern of VEGF changes using these reagents suggested cross-reactivity. Standard curves were plotted for concentrations between 31.2-2000 pg/ml and lower concentrations were extrapolated by assuming linearity to zero. The coefficient of variation is stated by the manufacturer to be approximately 5% when used on human plasma.
When plasma had just been sampled, the tympanic ear temperature was measured by a Genius Tympanic Model 3000A (Sherwood Medical, Ballymoney, UK). The result was reported as 1.44°C higher to account for the site of measurement.
The rabbit was rated as having a normal physical status or a slightly affected breathing pattern, or else as being more severely affected, as judged by altered breathing or changes in posture and reactivity.
Results were presented as the median and the 25th-75th percentile range. Changes during the experiment were studied using the Wilcoxon matched-pair test. Differences between the groups were evaluated by analysis of variance (ANOVA). P < 0.05 was considered significant.
RESULTS
There was an increase in the plasma concentration of VEGF from 1.5 pg/ml (1.2-19.7 pg/ml) at baseline to a maximum of 111 pg/ml (58-231 pg/ml) 5 h later (P < 0.001). The increase was statistically significant in all 3 subgroups (P < 0.01) and, although the controls showed a slightly higher peak, the difference was not significant (ANOVA on log-transformed data; Fig. 1 ).
The body temperature was 39.2°C (39.0-39.5°C) at baseline, and the fever that gradually developed in response to endotoxin correlated with the VEGF concentration at the same point in time (Fig. 2) .
The physical status of the rabbits recorded at the end of the first day of the experiment (at 9 h) also correlated with the peak VEGF concentration; animals that were normal or slightly affected by endotoxin had a peak concentration of 77 pg/ml (58-148 pg/ml) while 8 animals that were more affected had a VEGF concentration of 130 pg/ml (96-393 pg/ml). The 3 animals that died had even higher peaks: 213 pg/ml, 974 pg/ml and 1438 pg/ml. Fig. 1 . Time course of the plasma concentration of vascular endothelial growth factor (VEGF) in rabbits given 20 mg/kg of endotoxin alone at time 0 (controls) and in animals given 1000 IE/kg of retinyl palmitate 1 h before an injection of endotoxin (prophylaxis group, n = 10) or the same dose given 1 h after the endotoxin (treatment group, n = 10).
DISCUSSION
The results show a 100-fold increase in the plasma concentration of VEGF in response to a moderately large bolus injection of endotoxin. The peak occurred 5 h after the injection. Although vitamin A seemed to reduce the peak concentration slightly, the VEGF response was not significantly altered by a higher endotoxin clearance induced by vitamin A. As reported previously, the endotoxin activity at 180 min was approximately 20% of the peak value in the control group, but only 4-5% in the two groups that received vitamin A. 7 The similar VEGF patterns suggest that the up-regulation of VEGF is more dependent on the dose than on the rate of elimination of the endotoxin. The present results further demonstrate a correlation between VEGF response and the development of fever, and also that animals severely affected by the endotoxin had higher VEGF concentrations than the others.
These findings may be relevant to the signs and symptoms of endotoxinemia, since VEGF causes vasodilation and an acute increase in capillary permeability. 5 The cytokine also stimulates rapid growth of new blood vessels of a 'leaky' nature, and these might operate as early as the next day. Most studies of VEGF have focused on the its role in angiogenesis and tumor pathology, while its effect on vascular permeability has received relatively little attention. Neovascularization of the diabetic retina and endometriosis are diseases in which VEGF has been attributed a pathophysiological role. 9 VEGF also seems to be involved in benign prostatic growth, which is a very common disease in elderly men. 10 The development of these diseases occurs over a long period of time, however, while the effects of VEGF in endotoxinemia are likely to be more acute. In the rabbits studied here, the up-regulation of VEGF was probably a part of, and perhaps secondary to, a cascade of inflammatory cytokines (such as TNF-a) being released in response to the endotoxin. Previous work has demonstrated that VEGF rises in response to certain factors involved in the inflammatory cascade, such as hypoxia, endothelin-1 and interleukin-1, while nitric oxide (NO) acts as an inhibitor. 9 The main drawback of this study is the lack of reagents for analyzing rabbit plasma. The experiments were originally designed to evaluate the effect of vitamin A on endotoxin clearance, but an interest in studying the VEGF response increased with time. Preliminary analyses using the kits for human plasma showed a clear trend with respect to VEGF, and the final results show a fully consistent rise in response to endotoxin. Although the precise concentrations are probably higher than those presented here, the magnitude of the increase and the correlations between VEGF and the other parameters are likely to be valid.
To obtain some human data for comparison, the same reagents were used to measure the plasma VEGF concentration in 10 patients on the second day after hip surgery as well as in 10 sex-and age-matched healthy controls. The concentration averaged 101 pg/ml after surgery and 30 pg/ml in the controls. This result is consistent with the trend seen in the rabbit samples and indicates that trauma, regardless of whether it is induced by mechanical injury or endotoxin, induces a rise in the whole-body VEGF concentration.
CONCLUSIONS
A marked increase in VEGF concentration in response to a bolus injection of endotoxin suggests a potential role Endotoxin boosts the vascular endothelial growth factor (VEGF) in rabbits 99 for this cytokine in the sepsis syndrome, in particular with respect to vascular permeability and vasodilation. Further studies using blocking antibodies or knock-out animals are needed to elucidate its role in more detail.
